Rep. Thomas Kean Jr. discloses 6 stock transactions in ABT, ESAB, JNJ, MDLZ, SYK, and TXN
- Filer
- Hon. Thomas H. Kean Jr (NJ)
- Transactions
- 6 across 6 companies
- Direction
- 2 bought · 4 sold
- Notification date
- 10/07/2026
6 transactions in this filing
| Company | Ticker | Type | Amount | Date |
|---|---|---|---|---|
| Johnson & Johnson | JNJ | Sale | $1,001 - $15,000 | 09/30/2026 |
| Abbott Laboratories | ABT | Sale | $1,001 - $15,000 | 09/17/2026 |
and 4 more transactions in this filing
Representative Thomas H. Kean Jr. (NJ07) disclosed six stock transactions executed during September 2026. The filing includes four partial sales and two purchases, each falling within the $1,001 to $15,000 valuation bracket. Disclosed partial sales involved Abbott Laboratories (ABT), Mondelez International, Inc. (MDLZ), Johnson & Johnson (JNJ), and Stryker Corporation (SYK). The disclosed purchases involved ESAB Corporation (ESAB) and Texas Instruments Incorporated (TXN). The transactions were held under the Kean Family Partnership and State Street Bank & Trust Co. The filing includes an explanatory note stating that all transactions are initiated and made by third-party advisors with no input from Representative Kean. The report was digitally signed on October 30, 2026.
Important Disclaimer
Amounts are disclosed by law as broad ranges, not exact figures - this reflects the range as filed, not a precise dollar amount. This content is summarized from a public government disclosure filing and may contain errors.
The Filing Fool is not a registered investment adviser. Nothing here is a recommendation or solicitation to buy, sell, or hold any security, nor any claim about a filer's intent or knowledge.